A 74-year-old woman presented to our hospital with dyspnoea on exertion. She underwent mitral valve replacement (MVR) with a 27-mm-stented porcine valve and coronary artery bypass surgery for ruptured mitral chordae tendineae following inferior acute myocardial infarction 2 years ago. Postoperatively, she had been treated with vitamin K antagonist (VKA) and aspirin for 
a 27-mm-stented porcine valve and coronary artery bypass surgery for ruptured mitral chordae tendineae following inferior acute myocardial infarction 2 years ago. Postoperatively, she had been treated with vitamin K antagonist (VKA) and aspirin for 3 months, and VKA was discontinued thereafter. Even though serial transthoracic echocardiography examination demonstrated a gradual increase in the mitral transvalvular gradient and the inferior wall motion abnormality, she did not have any symptoms and both ventricular function was preserved. Upon admission, transoesophageal echocardiography (TOE) revealed thickened mitral leaflets with restricted motion and low echoic mass extended to the left atrial septal wall ( Figure 1C and 1D, Supplementary material online, Video S1). The peak mitral velocity and mean transmitral gradient increased to 2.5 m/s and 17 mmHg, respectively ( Figure 1B) . Additionally, the mitral valve area calculated by the continuity equation was 0.53 cm 2 . The bioprosthetic valve thrombosis (BPVT) was suspected because it occurs mostly within 2 years after valve replacement, 1 VKA was initiated instead of surgery or thrombolysis because she was hemodynamically stable without thromboembolic event. As we currently lack a precise understanding of the mechanism leading to BPVT, she was ultimately diagnosed with unprovoked BPVT. Careful follow-up is necessary even in the chronic phase after bioprosthetic valve replacement.
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Supplementary material
Supplementary material is available at European Heart Journal -Case Reports online.
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The author/s confirm that written consent for submission and publication of this case report including image(s) and A B C D Figure 2 Simultaneous multiplane imaging of two-dimensional transoesophageal echocardiography images (A) and three-dimensional transoesophageal echocardiography images in systole (C) and diastole (D) after 3-month treatment with vitamin K antagonist. The mitral leaflet thickness significantly decreased and valve opening markedly improved. In addition, thrombus in the atrial septum disappeared. The peak early mitral velocity and the mean transmitral gradient markedly decreased to 1.4 m/s and 2 mmHg, respectively (B). Because she had moderate aortic regurgitation, the Doppler spectrum of the mitral valve flow overlapped with the Doppler spectrum of the aortic regurgitation flow (B).
